EP1165076A4 - 6-azaindole compounds as antagonists of gonadotropin releasing hormone - Google Patents
6-azaindole compounds as antagonists of gonadotropin releasing hormoneInfo
- Publication number
- EP1165076A4 EP1165076A4 EP00912193A EP00912193A EP1165076A4 EP 1165076 A4 EP1165076 A4 EP 1165076A4 EP 00912193 A EP00912193 A EP 00912193A EP 00912193 A EP00912193 A EP 00912193A EP 1165076 A4 EP1165076 A4 EP 1165076A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antagonists
- releasing hormone
- gonadotropin releasing
- azaindole compounds
- azaindole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12364099P | 1999-03-10 | 1999-03-10 | |
US123640P | 1999-03-10 | ||
PCT/US2000/005933 WO2000053181A1 (en) | 1999-03-10 | 2000-03-06 | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1165076A1 EP1165076A1 (en) | 2002-01-02 |
EP1165076A4 true EP1165076A4 (en) | 2002-05-15 |
Family
ID=22409922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00912193A Withdrawn EP1165076A4 (en) | 1999-03-10 | 2000-03-06 | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1165076A4 (en) |
JP (1) | JP2002538206A (en) |
AU (1) | AU3396000A (en) |
CA (1) | CA2367126A1 (en) |
WO (1) | WO2000053181A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0022670D0 (en) | 2000-09-15 | 2000-11-01 | Astrazeneca Ab | Molecules |
SE0100566D0 (en) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
SE0101692D0 (en) | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Compounds |
US7253290B2 (en) | 2002-08-21 | 2007-08-07 | Astrazeneca Ab | Pyrazole derivatives as GnRH inhibitors |
TW200413351A (en) | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
WO2004018479A1 (en) | 2002-08-21 | 2004-03-04 | Astrazeneca Ab | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
GB0219472D0 (en) | 2002-08-21 | 2002-10-02 | Astrazeneca Ab | Chemical compounds |
TW200407127A (en) | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
PT1753764E (en) | 2004-06-09 | 2009-01-28 | Glaxo Group Ltd | Pyrrolopyridine derivatives |
CA3196620A1 (en) | 2020-10-05 | 2022-04-14 | Enliven Therapeutics, Inc. | 5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5849764A (en) * | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2298199A (en) * | 1995-02-21 | 1996-08-28 | Merck Sharp & Dohme | Synthesis of azaindoles |
US6025366A (en) * | 1998-04-02 | 2000-02-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
2000
- 2000-03-06 AU AU33960/00A patent/AU3396000A/en not_active Abandoned
- 2000-03-06 JP JP2000603670A patent/JP2002538206A/en not_active Withdrawn
- 2000-03-06 WO PCT/US2000/005933 patent/WO2000053181A1/en not_active Application Discontinuation
- 2000-03-06 EP EP00912193A patent/EP1165076A4/en not_active Withdrawn
- 2000-03-06 CA CA002367126A patent/CA2367126A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5849764A (en) * | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
Non-Patent Citations (1)
Title |
---|
See also references of WO0053181A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1165076A1 (en) | 2002-01-02 |
CA2367126A1 (en) | 2000-09-14 |
JP2002538206A (en) | 2002-11-12 |
AU3396000A (en) | 2000-09-28 |
WO2000053181A1 (en) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1171135A4 (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
EP1161431A4 (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
EP0986385A4 (en) | Antagonists of gonadotropin releasing hormone | |
EP1067930A4 (en) | Antagonists of gonadotropin releasing hormone | |
EP0986557A4 (en) | Antagonists of gonadotropin releasing hormone | |
AU4834900A (en) | Antagonists of gonadotropin releasing hormone | |
EP1165075A4 (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
EP1011667A4 (en) | Antagonists of gonadotropin releasing hormone | |
EP1027046A4 (en) | Antagonists of gonadotropin releasing hormone | |
EP0901471A4 (en) | Antagonists of gonadotropin releasing hormone | |
EP1049472A4 (en) | Antagonists of gonadotropin releasing hormone | |
EP0920319A4 (en) | Antagonists of gonadotropin releasing hormone | |
IL149107A0 (en) | Formulation of substituted benzimidazoles | |
EP1165076A4 (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
EP1171126A4 (en) | 6-azaindole compounds as antagonists of gonadotropin releasing hormone | |
PL350536A1 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor | |
EP1062215A4 (en) | Antagonists of gonadotropin releasing hormone | |
AU4742101A (en) | Antagonists of gonadotropin releasing hormone | |
AU4738101A (en) | Antagonists of gonadotropin releasing hormone | |
GB9907082D0 (en) | The preparation of carboxylic acid derivatives | |
GB9800450D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9815847D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9800451D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9811286D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9811294D0 (en) | Antagonists of gonadotropin releasing hormone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011010 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20011010;LT PAYMENT 20011010;LV PAYMENT 20011010;MK PAYMENT 20011010;RO PAYMENT 20011010;SI PAYMENT 20011010 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020402 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/437 A, 7A 61K 31/435 B, 7A 61K 31/495 B, 7A 61K 31/497 B, 7A 61K 31/498 B, 7A 61K 31/506 B, 7A 61K 31/517 B, 7A 61K 31/541 B, 7A 61K 31/5355 B, 7A 61P 5/04 B, 7C 07D 519/00 B, 7C 07D 471/04 B |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020614 |